A61K 47/552
One of the codrug's components being an antibiotic
Official title: {one of the codrug's components being an antibiotic}
A61K47/552 (One of the codrug's components being an antibiotic) appears on 85 US grants and 161 published applications in this corpus.
Search patents in A61K- Granted patents
- 85
- Published applications
- 161
- Assignees
- 117
- Inventors
- 378
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 3 |
| 2003 | 3 | 3 |
| 2004 | 0 | 5 |
| 2005 | 2 | 5 |
| 2006 | 1 | 5 |
| 2007 | 2 | 3 |
| 2008 | 1 | 7 |
| 2009 | 0 | 6 |
| 2010 | 1 | 7 |
| 2011 | 6 | 3 |
| 2012 | 2 | 5 |
| 2013 | 5 | 6 |
| 2014 | 2 | 5 |
| 2015 | 4 | 4 |
| 2016 | 3 | 2 |
| 2017 | 2 | 5 |
| 2018 | 3 | 6 |
| 2019 | 4 | 8 |
| 2020 | 5 | 7 |
| 2021 | 5 | 9 |
| 2022 | 4 | 24 |
| 2023 | 4 | 12 |
| 2024 | 5 | 5 |
| 2025 | 7 | 7 |
| 2026 | 7 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Oligonucleotides with nucleoside analogs21 Jul 2026US 12,685,775 B2Sirnaomics, Inc.
- Chemically coupled transporter for low-hydrophobicity bioactive drugs into the central nervous system26 May 2026US 12,636,371 B2Consejo Nacional de Investigaciones Cientificas y Tecnias (Conicet)
- Siderophore-dihydrofolate reductase inhibitor conjugate and application thereof12 May 2026US 12,622,974 B2Jasan Bio Medicine (Jiaxing) Co., Ltd
- Bisphosphonate quinolone conjugates and uses thereof12 May 2026US 12,624,057 B2Biovinc, LLC
- Compositions comprising fullerenyl mesochlorin nano-photosensitizers with covalently bound antibiotics and their uses in combination therapy10 Mar 2026US 12,570,665 B2University of Massachusetts
- Protease/enzyme cleavable linker-payloads and protein conjugates3 Sep 2026US 2026/0256929 A1
- Chemically Coupled Transporter for Low-Hydrophobicity Bioactive Drugs into the Central Nervous System13 Aug 2026US 2026/0232814 A1Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet)
- Bile acid-metronidazole conjugate and use thereof16 Jul 2026US 2026/0199482 A1South China University of Technology
- Use of compound in preparation of drug for treatment or prevention of mycobacterium tuberculosis infection9 Jul 2026US 2026/0191965 A1TenNor Therapeutics (Zhongshan) Limited
- Hybrid compounds of sclareol and doxorubicin, their synthesis and application25 Jun 2026US 2026/0174860 A1Institute for Biological Research "Sinisa Stankovic" - National Institute of the Republic of Serbia
Most cited
By later US patents
- Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand69US 6,372,712 B1Howard Hughes Medical Institute · 2002
- Multibinding inhibitors of microsomal triglyceride transferase protein58US 6,288,234 B1Advanced Medicine, Inc. · 2001
- Therapeutic polyanhydride compounds for drug delivery50US 6,613,807 B2Rutgers, The State University of New Jersey · 2003
- Particulate constructs for release of active agents40US 10,905,775 B2Celator Pharmaceuticals, Inc. · 2021
- Bisphosphonate quinolone conjugates and uses thereof33US 10,865,220 B2Biovinc, LLC · 2020